Transthyretin inhibition of amyloid beta aggregation and toxicity

The findings imply that experimental systems investigating Aβ-induced cytotoxicity consider the protective interaction of transthyretin with Aβ; an interaction to be considered also in vivo in view of the fact that transthyretin immunoreactivity has been previously demonstrated in amyloid plaques of brains from Alzheimer's disease patients.